Rare genetic syndromes under the microscope: what 800 participants could reveal
NCT ID NCT02447861
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to learn more about the medical and behavioral effects of two rare genetic conditions: 3q29 deletion and 3q29 duplication syndromes. Researchers will collect health and behavior data from 800 participants, including those with the syndromes and healthy siblings. The goal is to better understand the range of challenges these individuals face, which could improve future care and support.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide a clearer picture of the medical and behavioral challenges linked to 3q29 syndromes, helping guide future care and support.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve health. Results depend on participant reports and may not apply to everyone with these syndromes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MICRODELETION 3Q29 SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Internet-Based
RECRUITINGPiscataway, New Jersey, 08854, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••